Related references
Note: Only part of the references are listed.Exosome-derived circCCAR1 promotes CD8+T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
Zongqiang Hu et al.
MOLECULAR CANCER (2023)
The evolving role of immune cells in prostate cancer
Chao Wang et al.
CANCER LETTERS (2022)
MicroRNA-181a restricts human γδ T cell differentiation by targeting Map3k2 and Notch2
Gisela Gordino et al.
EMBO REPORTS (2022)
LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer
Wei Zhang et al.
IMMUNOBIOLOGY (2022)
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
Thomas Powles et al.
NATURE MEDICINE (2022)
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
Hirohito Yamaguchi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer
Shingo Maeda et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Long Noncoding RNAs Regulate the Inflammatory Responses of Macrophages
Qing Zhao et al.
CELLS (2022)
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial
Edmond M. Kwan et al.
EUROPEAN UROLOGY (2022)
Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Changfa Xia et al.
CHINESE MEDICAL JOURNAL (2022)
Androgen receptor activity in T cells limits checkpoint blockade efficacy
Xiangnan Guan et al.
NATURE (2022)
Targeting Cytotoxic T Cells to Tumor
Elizabeth G. Phimister et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou et al.
ACTA PHARMACEUTICA SINICA B (2022)
Blockade of exosome generation by GW4869 inhibits the education of M2 macrophages in prostate cancer
Yilin Peng et al.
BMC IMMUNOLOGY (2022)
Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1
Feng Gao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
LMX1B Activated Circular RNA GFRA1 Modulates the Tumorigenic Properties and Immune Escape of Prostate Cancer
Min Meng et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2022)
Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING/MAVS signaling pathway
Jiwei Zhang et al.
CANCER LETTERS (2022)
N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells
Zhihua Liu et al.
DRUG RESISTANCE UPDATES (2022)
CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling
Tao Xie et al.
MOLECULAR CANCER (2022)
Transgenic construction and functional miRNA analysis identify the role of miR-7 in prostate cancer suppression
Can Wang et al.
ONCOGENE (2022)
High dose androgen suppresses natural killer cytotoxicity of castration-resistant prostate cancer cells via altering AR/circFKBP5/miRNA-513a-5p/PD-L1 signals
Min Tang et al.
CELL DEATH & DISEASE (2022)
A New Promising Pathway in Aggressive Prostate Cancer: Treg/mir-let8c/lin28b
Ibrahim Akalin et al.
ARCHIVOS ESPANOLES DE UROLOGIA (2022)
Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
Zehua Ma et al.
THERANOSTICS (2022)
Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate cancer
Lei Wu et al.
BMC CANCER (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
TIGIT/PVR and LncRNA ANRIL dual-targetable PAMAM polymeric nanoparticles efficiently inhibited the hepatoma carcinoma by combination of immunotherapy and gene therapy
Tianyin Wang et al.
JOURNAL OF DRUG TARGETING (2021)
lncRNA PCAT14 Is a Diagnostic Marker for Prostate Cancer and Is Associated with Immune Cell Infiltration
Yunkun Yan et al.
DISEASE MARKERS (2021)
Immune response drives outcomes in prostate cancer: implications for immunotherapy
Jialin Meng et al.
MOLECULAR ONCOLOGY (2021)
Long noncoding RNA LINC00657 inhibits cervical cancer development by sponging miR-20a-5p and targeting RUNX3
Xiaomin Qin et al.
CANCER LETTERS (2021)
Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer
Sarah I. M. Sutherland et al.
FRONTIERS IN IMMUNOLOGY (2021)
The circular RNA circINPP4B acts as a sponge of miR-30a to regulate Th17 cell differentiation during progression of experimental autoimmune encephalomyelitis
Jingjing Han et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Prostate cancer
Shahneen Sandhu et al.
LANCET (2021)
Noncoding RNA therapeutics - challenges and potential solutions
Melanie Winkle et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Inhibition of STAT3/PD-L1 and Activation of miR193a-5p Are Critically Involved in Apoptotic Effect of Compound K in Prostate Cancer Cells
Jae-Hee Lee et al.
CELLS (2021)
A review of cancer immunotherapy toxicity
Lucy Boyce Kennedy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Revisiting Immunotherapy: A Focus on Prostate Cancer
Ha-Ram Cha et al.
CANCER RESEARCH (2020)
CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens
Neal D. Shore et al.
MOLECULAR THERAPY (2020)
Long non-coding RNA lnc-DC in dendritic cells regulates trophoblast invasion via p-STAT3-mediated TIMP/MMP expression
Wen Zhang et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2020)
T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer
Aleksandar Z. Obradovic et al.
CLINICAL CANCER RESEARCH (2020)
Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer
Han Guan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
CD4+ T helper 17 cell response of aged mice promotes prostate cancer cell migration and invasion
Sen Liu et al.
PROSTATE (2020)
The regulatory network among CircHIPK3, LncGAS5, and miR-495 promotes Th2 differentiation in allergic rhinitis
Xiaoyuan Zhu et al.
CELL DEATH & DISEASE (2020)
Live cell imaging and proteomic profiling of endogenous NEAT1 lncRNA by CRISPR/Cas9-mediated knock-in
Bohong Chen et al.
PROTEIN & CELL (2020)
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C. Parker et al.
ANNALS OF ONCOLOGY (2020)
Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 Locus
Marco Mineo et al.
MOLECULAR CELL (2020)
Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial
Padmanee Sharma et al.
CANCER CELL (2020)
LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1
Qi-Hua Chen et al.
CANCER CELL INTERNATIONAL (2020)
Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer
Jiping Rong et al.
CANCER CELL INTERNATIONAL (2020)
Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in Prostate Cancer by Stimulating LIF/LIFR Expression
Wei Zhang et al.
MOLECULAR THERAPY (2020)
A dendritic cell multitasks to tackle cancer
Marianne Burbage et al.
NATURE (2020)
Tackling TAMs for Cancer Immunotherapy: It's Nano Time
Yishun Yang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine
Simeng Wen et al.
MOLECULAR CANCER (2020)
Extracellular Vesicles-Mediated Transfer of miRNA Let-7b from PC3 Cells to Macrophages
Egidia Costanzi et al.
GENES (2020)
Tribbles-1 Expression and Its Function to Control Inflammatory Cytokines, Including Interleukin-8 Levels are Regulated by miRNAs in Macrophages and Prostate Cancer Cells
Chiara Niespolo et al.
FRONTIERS IN IMMUNOLOGY (2020)
The cancer-natural killer cell immunity cycle
Nicholas D. Huntington et al.
NATURE REVIEWS CANCER (2020)
Modulation of regulatory T cell function and stability by co-inhibitory receptors
Liliana E. Lucca et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Long non-coding RNA CCAT1/miR-148a/PKC zeta prevents cell migration of prostate cancer by altering macrophage polarization
Jie Liu et al.
PROSTATE (2019)
TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in heck for prostate cancer
Ze-Zhen Liu et al.
CELLULAR SIGNALLING (2019)
LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3
Peipei Fang et al.
INNATE IMMUNITY (2019)
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
Qingsong Hu et al.
NATURE IMMUNOLOGY (2019)
Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer
E. Richardsen et al.
SCIENTIFIC REPORTS (2019)
Current Knowledge of the Potential Links between Inflammation and Prostate Cancer
Tommaso Cai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy
Shiping Jiao et al.
CELL (2019)
Landscape of Noncoding RNA in Prostate Cancer
Junjie T. Hua et al.
TRENDS IN GENETICS (2019)
The Long Noncoding RNA TTTY15, Which Is Located on the Y Chromosome, Promotes Prostate Cancer Progression by Sponging let-7
Guang'an Xiao et al.
EUROPEAN UROLOGY (2019)
IL-8 Secreted from M2 Macrophages Promoted Prostate Tumorigenesis via STAT3/MALAT1 Pathway
Tingjin Zheng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Treating Disease at the RNA Level with Oligonucleotides
Arthur A. Levin
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis
G. Comito et al.
ONCOGENE (2019)
MDSC; the Most Important Cell You Have Never Heard Of
R. J. Tesi
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo et al.
NATURE REVIEWS IMMUNOLOGY (2019)
The Tumor Immune Contexture of Prostate Cancer
Natasha Vitkin et al.
FRONTIERS IN IMMUNOLOGY (2019)
Metastatic prostate cancer remains incurable, why?
Liang Dong et al.
ASIAN JOURNAL OF UROLOGY (2019)
T Helper Cell Differentiation, Heterogeneity, and Plasticity
Jinfang Zhu
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
The Phenotypic Effects of Exosomes Secreted from Distinct Cellular Sources: a Comparative Study Based on miRNA Composition
Scott Ferguson et al.
AAPS JOURNAL (2018)
HIF-1α induces immune escape of prostate cancer by regulating NCR1/NKp46 signaling through miR-224
Chao-hao Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint
Zhen Tao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Lnc-chop Promotes Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor and Inflammatory Environments
Yunhuan Gao et al.
JOURNAL OF IMMUNOLOGY (2018)
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options
Martin G. Sanda et al.
JOURNAL OF UROLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Therapeutic Targeting of Long Non-Coding RNAs in Cancer
Gayatri Arun et al.
TRENDS IN MOLECULAR MEDICINE (2018)
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
Patrick Danaher et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Lnc-DC regulates cellular turnover and the HBV-induced immune response by TLR9/STAT3 signaling in dendritic cells
Lifan Zhuang et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2018)
Biomedical applications of mRNA nanomedicine
Qingqing Xiong et al.
NANO RESEARCH (2018)
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
Arianna Calcinotto et al.
NATURE (2018)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
CircFAT1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells
Gang Liu et al.
MOLECULAR CANCER (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Blocking the Feedback Loop between Neuroendocrine Differentiation and Macrophages Improves the Therapeutic Effects of Enzalutamide (MDV3100) on Prostate Cancer
Chao Wang et al.
CLINICAL CANCER RESEARCH (2018)
Non-coding RNA networks in cancer
Eleni Anastasiadou et al.
NATURE REVIEWS CANCER (2018)
Inhibition of KPNA4 attenuates prostate cancer metastasis
J. Yang et al.
ONCOGENE (2017)
Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression
Ronghao Wang et al.
EUROPEAN UROLOGY (2017)
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
Tomasz M. Beer et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC
L. L. Bu et al.
JOURNAL OF DENTAL RESEARCH (2017)
Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies
Zoila Lopez-Bujanda et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Effective combinatorial immunotherapy for castration-resistant prostate cancer
Xin Lu et al.
NATURE (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
PKC in prostate cancer cells represses the recruitment and M2 polarization of macrophages in the prostate cancer microenvironment
Hui-hui Fan et al.
TUMOR BIOLOGY (2017)
The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion
Runqiu Jiang et al.
NATURE COMMUNICATIONS (2017)
LncRNA RNCR3 promotes Chop expression by sponging miR-185-5p during MDSC differentiation
Wencong Shang et al.
ONCOTARGET (2017)
Cancer-derived Circulating MicroRNAs Promote Tumor Angiogenesis by Entering Dendritic Cells to Degrade Highly Complementary MicroRNAs
Jiaqi Wang et al.
THERANOSTICS (2017)
Lnc-DC mediates the over-maturation of decidual dendritic cells and induces the increase in Th1 cells in preeclampsia
Wen Zhang et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2017)
Natural killer cells suppress enzalutamide resistance and cell invasion in the castration resistant prostate cancer via targeting the androgen receptor splicing variant 7 (ARv7)
Shin-Jen Lin et al.
CANCER LETTERS (2017)
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse
Valerio Nardone et al.
CANCER BIOLOGY & THERAPY (2016)
Regulation of prostate cancer progression by the tumor microenvironment
Stephen L. Shiao et al.
CANCER LETTERS (2016)
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer
Cora Sternberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Lin28b Regulates Fetal Regulatory T Cell Differentiation through Modulation of TGF-β Signaling
Yelena Bronevetsky et al.
JOURNAL OF IMMUNOLOGY (2016)
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1
Yuan Wang et al.
MOLECULAR CANCER (2016)
Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library
Shiyou Zhu et al.
NATURE BIOTECHNOLOGY (2016)
Patient-reported outcomes in metastatic castration-resistant prostate cancer
Lesley Fallowfield et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Dendritic Cells and Cancer Immunity
Alycia Gardner et al.
TRENDS IN IMMUNOLOGY (2016)
miRNA let-7b modulates macrophage polarization and enhances tumor-associated macrophages to promote angiogenesis and mobility in prostate cancer
Zhigang Wang et al.
SCIENTIFIC REPORTS (2016)
TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients
Dewan M. S. Hossain et al.
CLINICAL CANCER RESEARCH (2015)
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Xiaoyi Huang et al.
EUROPEAN UROLOGY (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11 -> miRNA-541 -> androgen receptor (AR) -> MMP9 signaling
Shuai Hu et al.
MOLECULAR ONCOLOGY (2015)
Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models
Li Shen et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells Potential effects on the tumor microenvironment
Jayoung Kim et al.
CANCER BIOLOGY & THERAPY (2014)
The Noncoding RNA Revolution-Trashing Old Rules to Forge New Ones
Thomas R. Cech et al.
CELL (2014)
The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors
Paul T. Thevenot et al.
IMMUNITY (2014)
Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction
Christian A. Bauer et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling
Andrea Koehler et al.
MOLECULAR CANCER (2014)
Comparative microRNA Profiling of Prostate Carcinomas with Increasing Tumor Stage by Deep Sequencing
Martin Hart et al.
MOLECULAR CANCER RESEARCH (2014)
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Eugene D. Kwon et al.
LANCET ONCOLOGY (2014)
Senescent stroma promotes prostate cancer progression: The role of miR-210
Maria Letizia Taddei et al.
MOLECULAR ONCOLOGY (2014)
The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation
Pin Wang et al.
SCIENCE (2014)
SOCS proteins in macrophage polarization and function
Heather M. Wilson
FRONTIERS IN IMMUNOLOGY (2014)
Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14+ PD-L1+ phenotype in prostate cancer
Lisa K. Spary et al.
ONCOIMMUNOLOGY (2014)
Downregulation and Prognostic Performance of MicroRNA 224 Expression in Prostate Cancer
Konstantinos Mavridis et al.
CLINICAL CHEMISTRY (2013)
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Shin-ichiro Ohno et al.
MOLECULAR THERAPY (2013)
Stimuli-responsive nanocarriers for drug delivery
Simona Mura et al.
NATURE MATERIALS (2013)
Hypoxia, notch signalling, and prostate cancer
Laure Marignol et al.
NATURE REVIEWS UROLOGY (2013)
MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells
X. Liu et al.
CELL DEATH & DISEASE (2013)
Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation
Yi Yin et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells
Chang G. Dong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells
Nagalakshmi Nadiminty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Role of Integrin-β3 Protein in Macrophage Polarization and Regeneration of Injured Muscle
Liping Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Differential Immunologic and MicroRNA Effects of 2 Dosing Regimens of Recombinant Human Granulocyte/Macrophage Colony Stimulating Factor
Pierre L. Triozzi et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tgf-β1 produced by activated CD4+ T Cells Antagonizes T Cell Surveillance of Tumor Development
Moses K. Donkor et al.
ONCOIMMUNOLOGY (2012)
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
Moses K. Donkor et al.
IMMUNITY (2011)
An Essential Role of the Transcription Factor GATA-3 for the Function of Regulatory T Cells
Yunqi Wang et al.
IMMUNITY (2011)
Non-coding RNAs in human disease
Manel Esteller
NATURE REVIEWS GENETICS (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
MicroRNA145 Targets BNIP3 and Suppresses Prostate Cancer Progression
Xueqin Chen et al.
CANCER RESEARCH (2010)
Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses
Li-Fan Lu et al.
CELL (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
B7 Blockade Alters the Balance between Regulatory T Cells and Tumor-reactive T Cells for Immunotherapy of Cancer
Penghui Zhou et al.
CLINICAL CANCER RESEARCH (2009)
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
David H. Raulet et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing
Karen Sandell Sfanos et al.
CLINICAL CANCER RESEARCH (2008)
Loss of mir-146a function in hormone-refractory prostate cancer
Shi-Lung Lin et al.
RNA (2008)
The role of myeloid cells in the promotion of tumour angiogenesis
Craig Murdoch et al.
NATURE REVIEWS CANCER (2008)
CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer
Yukiko Kiniwa et al.
CLINICAL CANCER RESEARCH (2007)
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2007)
Reversal of the TCR stop signal by CTLA-4
Helga Schneider et al.
SCIENCE (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
LFA-1 contributes an early signal for NK cell cytotoxicity
DF Barber et al.
JOURNAL OF IMMUNOLOGY (2004)
CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses
H Nishikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
STAT3 is required for FIM-dependent dendritic cell differentiation
Y Laouar et al.
IMMUNITY (2003)
TNF-alpha protects dendritic cells from prostate cancer-induced apoptosis
G Pirtskhalaishvili et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2001)
Eradication of established tumors by CD8+ T cell adoptive immunotherapy
HL Hanson et al.
IMMUNITY (2000)